China Medical Technologies, Inc. (CMED), a medical device company, announced Friday preliminary results for the fourth quarter and said its non-GAAP adjusted earnings from continuing operation per ADS increased by nearly 44% and revenues grew by about 37% year-over-year. The Beijing, China-based company stated that its non-GAAP adjusted income from continuing operation increased by about 43% year-over-year to approximately RMB 116 million or US$17 million and non-GAAP adjusted earnings from continuing operation per ADS increased by nearly 44% to about RMB 4.4 or US$0.6.
Revenues from continuing operations increased by about 37% over last year to nearly RMB 248 million or US$36 million. For fiscal year 2009, China Medical said its non-GAAP adjusted income from continuing operation increased by nearly 79% to about RMB 416 million or US$61 million and non-GAAP adjusted earnings from continuing operation per ADS grew by about 80% over the prior year to approximately RMB 15.8 or US$2.3. Revenues for the year from continuing operation improved by about 51% over last year to nearly RMB 829 million or US$121 million, the company noted.
China Medical said the adjusted results exclude the impact of stock compensation expense, amortization of acquired intangible assets and acquired in-process research and development charge.
The company expects to report its fourth-quarter and full-year results in late July 2009. CMED closed Thursday's regular trading at $22.9 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.